ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,108Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 153

$543K Total Retail Price of All Prescriptions

Rank: 8 out of 153

408 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 9,526 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 623 546 1 1
FUROSEMIDE 520 441 2 6
SIMVASTATIN 426 365 3 2
LISINOPRIL 424 381 4 3
AMLODIPINE BESYLATE 386 371 5 7
WARFARIN SODIUM 296 279 6 10
HYDROCODONE-ACETAMINOPHEN 288 252 S3 7 5
POTASSIUM CHLORIDE 260 225 8 12
OMEPRAZOLE 255 211 9 4
MIRTAZAPINE 243 220 10 47
PRAVASTATIN SODIUM 242 176 11 20
SERTRALINE HCL 231 205 12 16
METFORMIN HCL 218 186 13 8
FAMOTIDINE 180 178 14 54
GABAPENTIN 169 151 15 15
HYDROCHLOROTHIAZIDE 168 155 16 9
TRAZODONE HCL 158 131 17 32
METOPROLOL TARTRATE 153 127 18 11
TAMSULOSIN HCL 136 130 19 24
ATORVASTATIN CALCIUM 127 114 20 19
ALENDRONATE SODIUM 125 110 21 22
NAMENDA 125 125 21 28
METOPROLOL SUCCINATE 118 118 23 13
FENTANYL 101 100 S2 24 56
FINASTERIDE 100 100 25 102
CITALOPRAM HBR 96 80 26 14
DONEPEZIL HCL 92 92 27 26
SPIRIVA 90 71 28 35
LOSARTAN POTASSIUM 89 89 29 17
PROPRANOLOL HCL 74 74 30 111
ALLOPURINOL 70 63 31 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 65 32 33
CARVEDILOL 67 56 33 36
ISOSORBIDE MONONITRATE ER 67 67 33 81
ESCITALOPRAM OXALATE 66 63 35 55
METFORMIN HCL ER 65 65 36 45
LANTUS 65 65 36 44
CLOPIDOGREL 64 59 38 65
BUSPIRONE HCL 62 58 39 71
PREDNISONE 61 50 40 29
POLYETHYLENE GLYCOL 3350 61 51 40 41
SPIRONOLACTONE 60 56 42 48
JANUVIA 59 59 43 63
ZOLPIDEM TARTRATE 59 47 43 21
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 43 46
PANTOPRAZOLE SODIUM 58 56 46 30
DIOVAN HCT 56 44 47 98
BACLOFEN 56 24 47 109
DIVALPROEX SODIUM 56 39 47 66
NEXIUM 51 38 50 37
ATENOLOL 51 42 50 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.